secwatch.observer — SEC 8-K summary
======================================

Issuer:     aTYR PHARMA INC (ATYR)
CIK:        0001339970
Form:       8-K
Filed at:   2021-09-16T23:59:59+00:00
Accession:  0001564590-21-048145
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

aTyr Pharma prices $75M public offering of 9.375M shares at $8.00 per share
---------------------------------------------------------------------------

- Gross proceeds expected ~$75M from 9,375,000 shares at $8.00/share.
- Underwriters granted 30-day option to purchase up to 1,406,250 additional shares.
- Offering expected to close on September 20, 2021, subject to customary conditions.
- Joint book-running managers: Piper Sandler and RBC Capital Markets; Laidlaw & Co. as lead manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339970/000156459021048145/0001564590-21-048145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339970/000156459021048145/life-8k_20210915.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-048145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer